Abstract:BackgroundHepatocellular carcinoma (HCC) is the most commonly diagnosed malignancy of the liver, occurs frequently in the setting of chronic liver injury. Although multiple therapeutic approaches are available, the prognosis of patients with HCC remains poor. Dioscin is a natural steroid saponin that presents in various plants. The anti-cancer and anti-fibrotic effects have been extensively reported. However, the effect of dioscin on HCC remains unclear. We aimed to investigate the anti-HCC properties of dioscin in vitro and in vivo.MethodsMTT (3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl-tetrazolium bromide) assay was used to analyze the growth inhibition activity of Dioscin in human cell lines, Bel-7402, HepG2, Lovo, and EAhy926. Antitumor activity through induction of apoptosis was evaluated by flow cytometry using Annexin-V and propidium iodide (PI) staining, laser scanning confocal microscopy (LSCM) analysis with Hochest33342 and PI labeling, and DNA fragmentation analysis. The expression of apoptosis-related proteins tumor protein p53 (TP53), BCL2-associated X protein (BAX), B-Cell CLL/Lymphoma 2 (BCL2) and Caspase 3 (CASP3) was measured by Western blot. Nude mice bearing Bel-7402 were administered intraperitoneally at different doses of dioscin and 5-FU (5-Fluorouracil) treatment was used as a control. Tumor volume and tumor weight of each mouse were then measured.ResultsWe demonstrated that Dioscin inhibited proliferation of HCC cell lines in a dose-dependent manner. Dioscin also significantly induced morphological changes during death by apoptosis and increased DNA damage of Bel-7402 cells. Moreover, we demonstrated that Dioscin displayed anticancer activity via up-regulating expression of TP53, BAX and CASP3 protein, as well as down-regulating BCL2 in Bel-7402 cells. Notably, the in vivo anticancer activity of Dioscin was further assessed and achieved greater inhibition efficiency at the concentration increased to 24mg/kg/day than 5-FU at dose of 10mg/kg/day in nude mice bearing Bel-7402 cells.ConclusionsDioscin inhibited tumor growth via inducing apoptosis, which was accompanied by altered expression of apoptotic pathway proteins, such as TP53, BAX, BCL2 and CASP3. Our findings indicate that further evaluation of dioscin as a novel therapeutic approach for HCC is warranted.

Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line.

Dioscin (saponin)-induced generation of reactive oxygen species through mitochondria dysfunction: a proteomic-based study.

Proteomic approach to study the cytotoxicity of dioscin (saponin).

The mitotic-arresting and apoptosis-inducing effects of diosgenyl saponins on human leukemia cell lines.

Dioscin Facilitates ROS-induced Apoptosis Via the P38-Mapk/hsp27-mediated Pathways in Lung Squamous Cell Carcinoma

Apoptosis Induced By Dioscin In Hela Cells

Effects of Two Saponins Extracted from the Polygonatum Zanlanscianense Pamp on the Human Leukemia (Hl-60) Cells

Dioscin Suppresses Hepatocellular Carcinoma Tumor Growth by Inducing Apoptosis and Regulation of TP53, BAX, BCL2 and Cleaved CASP3.

Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer Via Promoting C-Myc Ubiquitination and Subsequent Hexokinase-2 Suppression

Diosgenin Induces Cell Cycle Arrest and Apoptosis in Human Leukemia K562 Cells with the Disruption of Ca2+ Homeostasis

Dioscin-induced apoptosis of human LNCaP prostate carcinoma cells through activation of caspase-3 and modulation of Bcl-2 protein family

Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins.

Apoptotic Effects of Diosgeninlactoside on Oral Squamous Carcinoma Cells in Vitro and in Vivo

Dioscin Inhibits Colon Tumor Growth and Tumor Angiogenesis Through Regulating VEGFR2 and AKT/MAPK Signaling Pathways

Dioscin Inhibits the Growth of Human Osteosarcoma by Inducing G2/M‐phase Arrest, Apoptosis, and GSDME‐dependent Cell Death in Vitro and in Vivo

Diosgenin Induces ROS-dependent Autophagy and Cytotoxicity Via Mtor Signaling Pathway in Chronic Myeloid Leukemia Cells

Dioscin inhibits human endometrial carcinoma proliferation via G0/G1 cell cycle arrest and mitochondrial-dependent signaling pathway

Dioscin-6 '-O-acetate Inhibits Lung Cancer Cell Proliferation Via Inducing Cell Cycle Arrest and Caspase-Dependent Apoptosis

Dioscin Promotes Prostate Cancer Cell Apoptosis and Inhibits Cell Invasion by Increasing SHP1 Phosphorylation and Suppressing the Subsequent MAPK Signaling Pathway

Diosgenyl Saponin Inducing Endoplasmic Reticulum Stress and Mitochondria-Mediated Apoptotic Pathways in Liver Cancer Cells.

Dioscin Induces Gallbladder Cancer Apoptosis By Inhibiting Ros-Mediated Pi3k/Akt Signalling